DE1211357B - Verfahren zum Stabilisieren von Catechinaminen - Google Patents

Verfahren zum Stabilisieren von Catechinaminen

Info

Publication number
DE1211357B
DE1211357B DER32552A DER0032552A DE1211357B DE 1211357 B DE1211357 B DE 1211357B DE R32552 A DER32552 A DE R32552A DE R0032552 A DER0032552 A DE R0032552A DE 1211357 B DE1211357 B DE 1211357B
Authority
DE
Germany
Prior art keywords
adrenaline
solutions
boric acid
solution
sodium bisulfite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DER32552A
Other languages
German (de)
English (en)
Inventor
Sidney Riegelman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
Original Assignee
University of California Berkeley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley filed Critical University of California Berkeley
Publication of DE1211357B publication Critical patent/DE1211357B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DER32552A 1961-04-28 1962-04-26 Verfahren zum Stabilisieren von Catechinaminen Pending DE1211357B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US106237A US3149035A (en) 1961-04-28 1961-04-28 Stabilization of epinephrine

Publications (1)

Publication Number Publication Date
DE1211357B true DE1211357B (de) 1966-02-24

Family

ID=22310285

Family Applications (1)

Application Number Title Priority Date Filing Date
DER32552A Pending DE1211357B (de) 1961-04-28 1962-04-26 Verfahren zum Stabilisieren von Catechinaminen

Country Status (6)

Country Link
US (1) US3149035A (enExample)
BE (1) BE617022A (enExample)
CH (1) CH431817A (enExample)
DE (1) DE1211357B (enExample)
GB (1) GB930452A (enExample)
NL (1) NL277824A (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526698A (en) * 1968-04-11 1970-09-01 Merck & Co Inc Stabilization of levo-3-(3,4-dihydroxyphenyl)-2-methylalanine with sodium bisulfite and sorbitol
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US4220636A (en) * 1978-11-07 1980-09-02 Deutsche Gesellschaft fuer Unwelt-Schutz e. V. Stabilized suppositories containing ergo-alkaloids
US4623664A (en) 1985-10-31 1986-11-18 University Of Iowa Research Foundation Oil suspended phenylephrine
US4689223A (en) * 1986-04-24 1987-08-25 T & R Chemicals, Inc. Method of treating the symptoms of the common cold
JPS635091A (ja) * 1986-06-26 1988-01-11 Senjiyu Seiyaku Kk 着色防止方法
US8628805B2 (en) * 2009-06-04 2014-01-14 Alk Ag Stabilized composition comprising at least one adrenergic compound
WO2010139752A2 (en) * 2009-06-04 2010-12-09 Alk Ag Stabilised composition comprising at least one adrenergic compound
US20120101167A1 (en) 2010-10-25 2012-04-26 Langham Maurice E Treatment of ocular and cerebral ischemia
AU2013328393A1 (en) 2012-10-08 2015-04-09 Wockhardt Limited Stable injectable pharmaceutical composition of epinephrine or salts thereof
EP3687475A4 (en) 2017-09-26 2021-07-28 YS Pharmtech STABILIZATION OF EPINEPHRIN FORMULATIONS
JP2020536926A (ja) 2017-10-10 2020-12-17 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ Ｌ−エピネフリンの安定化注射用医薬用組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2382546A (en) * 1941-11-03 1945-08-14 Curtis David Anesthetic solutions
US2391552A (en) * 1942-02-25 1945-12-25 Curtis David Stabilized aromatic compounds
US2493471A (en) * 1945-06-04 1950-01-03 Parke Davis & Co Stabilized organic compounds and methods of obtaining the same
US2783132A (en) * 1953-08-12 1957-02-26 Pennsylvania Salt Mfg Co Stabilization of hydrogen peroxide
US2948680A (en) * 1957-03-15 1960-08-09 Standard Oil Co Lubricant compositions

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
US3149035A (en) 1964-09-15
BE617022A (enExample)
CH431817A (de) 1967-03-15
GB930452A (en) 1963-07-03
NL277824A (enExample)

Similar Documents

Publication Publication Date Title
WO1997038674A1 (de) Ophthalmische zusammensetzung mit verlängerter verweilzeit am auge
DE69004066T2 (de) Verfahren zur photostabilisierung von augenspüllösungen.
DE602005002495T2 (de) Injizierbare Formulierung mit Natriumdiclofenac, Beta-Cyclodextrin und einem Polysorbat
DE69106990T2 (de) Poviden-Jod enthaltende pharmazeutische Zubereitung.
DD150694A1 (de) Verfahren zur stabilisierung von pharmazeutischen praeparaten mit oxidationsempfindlichen bestandteilen
EP0349797B1 (de) Stabilisierte, N-acetylcysteinhaltige Arzneimittelzubereitung
DE1467749A1 (de) Verfahren zur Herstellung von stabilen Tetracyclinpraeparaten
AT401469B (de) Pharmazeutische wässrige lösung zur parenteralen anwendung enthaltend einen in situ gebildeten komplex von einem alkaloid mit bis-indol-gerüst, sowie verfahren zu deren herstellung
DE19530708C2 (de) Pharmazeutisches Präparat mit trypanoziden Eigenschaften
DE1667900B2 (de) Schnell wirkende, beständige Rinderinsulinlösung
DE1203909B (de) Verfahren zum Stabilisieren waessriger Dispersionen von Lipoid-Thromboplastin
Ito Zytologische Untersuchungen über die Ganglienzellen des japanischen medizinischen Blutegels, Hirudo nipponica, mit besonderer Berücksichtigung auf die “dunkle Ganglienzelle.”
DE1262512B (de) Stabilisierte germicide Massen auf der Basis von Halogensalicylaniliden
DE1237107B (de) Verfahren zur Herstellung von Tetracyclinfusidat, des Salzes der Fusidinsaeure mit Tetracyclin
Groh et al. ORALE DAUERTHERAPIE MIT CLONAZEPAM (Ro 5‐4023) BEI EPILEPSIEN DES KINDES‐UND JUGENDALTERS
DE2122278A1 (de) Verfahren zum Haltbarmachen von Antiacidum-Zusammensetzungen
DE69124248T2 (de) Chlordioxid enthaltendes Mittel gegen Fischparasiten
EP0108248B1 (de) Lösungsvermittlerfreie, wässrige Nitroglycerinlösung
DE1252610B (de) Verfahren zum Stabilisieren von Katalase
DE2165373B2 (de) Stabilisation von antibiotischen loesungen
DE1188244B (de) Zubereitung mit biozider Wirkung
DE2659828A1 (de) Mittel fuer die behandlung von insektenstichen
DE1617275C (de) Röntgenkontrastmittel
DE416982C (de) Verfahren zur Vertilgung von Wanzen
DE317509C (enExample)